Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for January 2008.

Pharmaceutical Technology
Volume 32, Issue 1

Certifications
FAA Certifies AcuTemp Container


The "RKN" refrigeration container from AcuTemp.
AcuTemp Thermal Systems (Dayton, OH), a leading designer and manufacturer of high-performance insulation and temperature-sensitive packaging, announced that its "RKN" temperature-controlled air-cargo container received Federal Aviation Administration (FAA) approval. FAA granted the approval to AmSafe Bridport (Phoenix, AZ), AcuTemp's partner in the certification process. AcuTemp says the approval marks the first instance that FAA has certified a compressor-driven refrigeration unit, thus permitting its use in the cargo section of an aircraft. The container was designed to allow the air-cargo industry to transport and precisely manage temperatures of perishable items such as vaccines, pharmaceuticals, and reagents.

Vetter Is Certified to Work in Japan

Japan's Ministry for Health, Labor and Welfare gave Vetter Pharma-Fertigung (Ravensburg, Germany) accreditation as a foreign manufacturer for the Japanese pharmaceutical market. Vetter provides aseptic filling of prefilled injection systems. The company was certified in the "drug, sterile product;" "drug, packaging, labeling, and storage;" and "medical device, sterilized medical device" categories.

Expansions
Microfluidics Launches New Website

Microfluidics (Newton, MA) launched its newly redesigned website. The site ( http://www.microfluidicscorp.com/) provides clients an in-depth view of the company and its products using an intuitive navigation system and multimedia content. Visitors can view company news, upcoming events, press releases, newsletters, and industry-specific solutions. The items are organized into categories such as pharmaceutical, biotechnology, and chemical. Visitors also can search for information about topics such as cell disruption, high-shear particle-size reduction, liposomes, emulsions, and carbon nanotubes.

DRAXIS Builds New Facility

DRAXIS Health (Montreal, Canada) began constructing a 77,000-ft2 new secondary-packaging and warehousing facility in St-Anne-de-Bellevue, Quebec. The facility will help DRAXIS produce multiple nonsterile specialty semisolid products for Johnson & Johnson Consumer Companies (Skillman, NJ). The new building is expected to be completed by mid-2008. DRAXIS then will install and validate the facility's equipment and ensure the facility complies with the applicable regulatory requirements.

Advion BioServices Acquires New Instruments

Advion BioServices (Ithaca, NY) the bioanalytical services division of Advion BioSciences, is expanding its capacity with the recent acquisition of two Applied Biosystems–MDS Sciex "API 5000" mass spectrometers and Waters "Acquity" ultraperformance liquid chromatography (UPLC) capability. In addition, the company hired 17 employees after moving to its new laboratory facility in April 2007.

Advion has operated a bioanalytical liquid chromatography–mass spectrometry laboratory since 1993 to serve the pharmaceutical industry. The addition of the new API 5000 mass spectrometers gives Advion's bioanalytical laboratory a total of 24 triple-quadrupole mass spectrometers, thus making it one of the largest bioanalytical contract laboratories in the world. Advion's acquisition of UPLC broadens the range of liquid-chromatography capabilities the company can offer its customers.


ADVERTISEMENT

RELATED CONTENT
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here